Yes. As of September 2026, Roquefort Therapeutics PLC (ROQ.L) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Roquefort Therapeutics PLC passes Musaffa's business and financial screening criteria.
Roquefort Therapeutics Plc operates as an investment company. The firm is engaged in preclinical development of next generation medicines focused on hard-to treat cancers. The Company’s portfolio consists of over five novel patent-protected pre-clinical anti-cancer medicines. Its portfolio of medicines include Midkine antibodies with in vivo efficacy and toxicology studies, and orphan drug indication; Midkine RNA oligonucleotide therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics targeting solid tumors; STAT-6 siRNA therapeutics targeting solid tumors with significant in vivo efficacy, and MK cell therapy with direct and Natural Killer cell-mediated anti-cancer action. The firm has partnered with leading academic cancer research centers which complement its own in-house expertise and laboratory infrastructure.
Roquefort Therapeutics PLC ROQ.L
GBX8.50
Last Updated: Sep 07, 12:00 AM·LSE
Pricing for GB stocks is delayed by 24 hours
ROQ.L Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Roquefort Therapeutics PLC is classified as halal.
HALAL
Report Source: undefined Quarter Report
Roquefort Therapeutics PLC (ROQ.L) Chart
Financial Metrics & Statements of Roquefort Therapeutics PLC (ROQ.L)
FAQ's for Roquefort Therapeutics PLC (ROQ.L)
As of September 2026, Roquefort Therapeutics PLC ROQ.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Roquefort Therapeutics PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in Roquefort Therapeutics PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Roquefort Therapeutics PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Roquefort Therapeutics PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Roquefort Therapeutics PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Roquefort Therapeutics PLC (ROQ.L)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.